The role for monocyte chemoattractant protein-1 in the generation and function of memory CD8+ T cells

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 2886-2893

  Wang, Tao ^a,b   Dai, Hehua ^a   Wan, Ni ^a   Moore, Yolonda ^a   Dai, Zhenhua ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; MONOCYTE CHEMOTACTIC PROTEIN 1; CCL2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL SURVIVAL; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; HOMEOSTASIS; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INTERFERON PRODUCTION; LIVER; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL DIFFERENTIATION; CELL LINE; CELL MOTION; CELL PROLIFERATION; COMPARATIVE STUDY; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KIDNEY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE; TRANSPLANTATION TOLERANCE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CHEMOKINE CCL2; FEMALE; IMMUNOLOGIC MEMORY; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION TOLERANCE;

EID: 49149131598     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.2886     Document Type: Article

References (56)

1. Dutton, R. W., L. M. Bradley, and S. L. Swain. 1998. T cell memory. Annu. Rev. Immunol. 16: 201-223.
2. Sprent, J., and C. D. Surh. 2002. T cell memory. Annu. Rev. Immunol. 20: 551-579.
3. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272: 54-60.
4. + T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J. Immunol. 169: 4667-4673.
5. + T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J. Immunol. 172: 5456-5466.
6. + T cells via a CD30-dependent mechanism. J. Clin. Invest. 113: 310-317.
7. + T cells play a critical role in costimulation blockade-resistant allograft rejection. J. Clin. Invest. 104: 1715-1722.
8. Shiao, S. L., J. M. McNiff, and J. S. Pober. 2005. Memory T cells and their costimulators in human allograft injury. J. Immunol. 175: 4886-4896.
9. Vu, M. D., M. R. Clarkson, H. Yagita, L. A. Turka, M. H. Sayegh, and X. C. Li. 2006. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J. Immunol. 176: 1394-1401.
10. Heeger, P. S., N. S. Greenspan, S. Kuhlenschmidt, C. Dejelo, D. E. Hricik, J. A. Schulak, and M. Tary-Lehmann. 1999. Pretransplant frequency of donor-specific, IFN-γ-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection epidodes. J. Immunol. 163: 2267-2275.
11. Wu, Z., S. J. Bensinger, J. Zhang, C. Chen, X. Yuan, X. Huang, J. F. Markmann, A. Kassaee, B. R. Rosengard, W. W. Hancock, et al. 2003. Homeostatic proliferation is a barrier to transplantation tolerance. Nat. Med. 10: 87-92.
12. Nasr, I. W., Y. Wang, G. Gao, S. Deng, L. Diggs, D. M. Rothstein, G. Tellides, F. G. Lakkis, and Z. Dai. 2005. Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells. J. Immunol. 174: 6161-6168.
13. Zhang, Y., G. Joe, E. Hexner, J. Zhu, and S. G. Emerson. 2005. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J. Immunol. 174: 3051-3058.
14. Lakkis, F. G., and M. H. Sayegh. 2003. Memory T cells: a hurdle to immunologic tolerance. J. Am. Soc. Nephrol. 14: 2402-2410.
15. Zhang, Q., Y. Chen, R. L. Fairchild, P. S. Heeger, and A. Valujskikh. 2006. Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J. Immunol. 176: 770-777.
16. + T cell help. J. Immunol. 176: 2316-2323.
17. Neujahr, D. C., C. Chen, X. Huang, J. F. Markmann, S. Cobbold, H. Waldmann, M. H. Sayegh, W. W. Hancock, and L. A. Turka. 2006. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J. Immunol. 176: 4632-4639.
18. Northrop, J. K., R. M. Thomas, A. D. Wells, and H. Shen. 2006. Epigenetic remodeling of the IL-2 and IFN-γ loci in memory CD8 T cells is influenced by CD4 T cells. J. Immunol. 177: 1062-1069.
19. Obhrai, J. S., M. H. Oberbarnscheidt, T. W. Hand, L. Diggs, G. Chalasani, and F. G. Lakkis. 2006. Effector T cell differentiiation and memory T cell maintenance outside secondary lymphoid organs. J. Immunol. 176: 4051-4058.
20. Williams, M. B., and E. C. Butcher. 1997. Homing of naive and memory T lymphocyte subsets to Peyer's patches, lymph nodes, and spleen. J. Immunol. 159: 1746-1752.
21. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18: 593-620.
22. Campbell, J. J., and E. C. Butcher. 2000. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr. Opin. Immunol. 12: 336-341.
23. Bradley, L. M. 2003. Migration and T-lymphocyte effector function. Curr. Opin. Immunol. 15: 343-348.
24. Fuentes, M. E., S. K. Durham, M. R. Swerdel, A. C. Lewin, D. S. Barton, J. R. Megill, R. Bravo, and S. A. Lira. 1995. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J. Immunol. 155: 5769-5776.
25. Gunn, M. D., N. A. Nelken, X. Liao, and L. T. Williams. 1997. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J. Immunol. 158: 376-383.
26. Lu, B., B. J. Rutledge, L. Gu, J. Fiorillo, N. W. Lukacs, S. L. Kunkel, R. North, C. Gerard, and B. J. Rollins. 1998. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187: 601-608.
27. Carr, M. W., S. J. Roth, E. Luther, S. S. Rose, and T. A. Springer. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 91: 3652-3656.
28. Moser, B., and P. Loetscher. 2001. Lymphocyte traffic control by chemokines. Nat. Immunol. 2: 123-128.
29. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187: 129-134.
30. Gu, L., S. Tseng, R. M. Horner, C. Tam, M. Loda, and B. J. Rollins. 2000. Control of Th2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404: 407-411.
31. Luther, S. A., and J. G. Cyster. 2001. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2: 102-107.
32. Traynor, T. R., A. C. Herring, M. E. Dorf, W. A. Kuziel, G. B. Toews, and G. B. Huffnagle. 2002. Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of Th1 immunity. J. Immunol. 168: 4659-4666.
33. Boring, L., J. Gosling, S. W. Chensue, S. L. Kunkel, R. V. Farese, H. E. Broxmeyer, and I. F. Charo. 1997. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in CC-chemokine receptor 2 knockout mice. J. Clin. Invest. 100: 2552-2561.
34. Kuziel, W. A., S. J. Morgan, T. C. Dawson, S. Griffin, O. Smithies, K. Ley, and N. Maeda. 1997. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. USA 94: 12053-12057.
35. Kurihara, T. G., G. Warr, J. Loy, and R. Bravo. 1997. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186: 1757-1762.
36. Fife, B. T., G. B. Huffnagle, W. A. Kuziel, and W. J. Karpus. 2000. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192: 899-906.
37. Izikson, L., R. S. Klein, I. F. Charo, H. L. Weiner, and A. D. Luster. 2000. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor CCR2. J. Exp. Med. 192: 1075-1080.
38. Hancock, W. W., B. Lu, W. Gao, V. Csizmadia, K. Faia, J. A. King, S. T. Smiley, M. Ling, N. P. Gerard, and C. Gerard. 2000. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192: 1515-1520.
39. Hancock, W. W., L. Wang, Q. Ye, R. Han, and I. Lee. 2003. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr. Opin. Immunol. 15: 479-486.
40. Gao, W., P. S. Topham, J. A. King, S. T. Smiley, V. Csizmadia, B. Lu, C. Gerard, and W. W. Hancock. 2000. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J. Clin. Invest. 105: 35-44.
41. Haskell, C. A., W. W. Hancock, D. J. Salant, W. Gao, V. Csizmadia, W. Peters, K. Faia, O. Fituri, J. B. Rottman, and I. F. Charo. 2001. Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection. J. Clin. Invest. 108: 679-688.
42. Abdi, R., R. N. Smith, L. Makhlouf, N. Najafian, A. D. Luster, H. J. Auchincloss, and M. H. Sayegh. 2002. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Diabetes 51: 2489-2495.
43. Lee, I., L. Wang, A. D. Wells, Q. Ye, R. Han, M. E. Dorf, W. A. Kuziel, B. J. Rollins, L. Chen, and W. W. Hancock. 2003. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J. Immunol. 171: 6929-6935.
44. Schroppel, B., N. Zhang, P. Chen, W. Zang, D. Chen, K. L. Hudkins, W. A. Kuziel, R. Sung, J. S. Bromberg, and B. Murphy. 2004. Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways. J. Am. Soc. Nephrol. 15: 1853-1861.
45. Fleury, S., J. Li, E. Simeoni, E. Fiorini, L. K. von Segesser, L. Kappenberger, and G. Vassalli. 2006. Gene transfer of RANTES and MCP-1 chemokine antagonists prolongs cardiac allograft survival. Gene Ther. 13: 1104-1109.
46. Haskova, Z., A. Izawa, A. G. Contreras, E. Flynn, G. Boulday, and D. M. Briscoe. 2007. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection. Transplantation 83: 1595-1601.
47. Liu, Z. W., H. Dai, N. Wan, T. Wang, S. Bertera, M. Trucco, and Z. Dai. 2007. Suppression of memory CD8 T cell generation and function by tryptophan catabolism. J. Immunol. 178: 4260-4266.
48. Wang, Y., H. Dai, Z. Liu, X. Cheng, G. Tellides, and Z. Dai. 2006. Neutralizing IL-7 promotes long-term allograft survival induced by CD40/CD40L costimulatory blockade. Am. J. Transplant. 6: 2851-2860.
49. Piemonti, L., B. Eugenio, R. Nano, A. Saccani, P. Monti, P. Maffi, G. Bianchi, A. Sica, G. Peri, R. Melzi, et al. 2002. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 51: 55-65.
50. Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrançois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417.
51. Reinhardt, R. L., A. Khoruts, R. Merica, T. Zell, and M. K. Jenkins. 2001. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410: 101-105.
52. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
53. Diaz-Guerra, E., R. Vernal, M. Julieta del Prete, A. Silva, and J. A. Garcia-Sanz. 2007. CCL2 inhibits the apoptosis program induced by growth factor deprivation, rescuing functional T cells. J. Immunol. 179: 7352-7357.
54. Dai, Z., and F. G. Lakkis. 2001. Cutting edge: Secondary lymphoid organs are essential for maintaining the CD4, but not CD8, naive T cell pool. J. Immunol. 167: 6711-6715.
55. Homann, D., L. Teyton, and M. B. A. Oldstone. 2001. Differential regulation of antiviral T-cell immunity results in stable CD8 but declining CD4 T-cell memory. Nat. Med. 7: 913-919.
56. + T cells. Am. J. Transplant. 3: 543-551.